Genetic Testing and Personalized Dosing Without Insurance Barriers PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after the first month) to identify how individual genetic variants in pathways like GLP1R, GIPR, FTO, and MC4R influence response to semaglutide and tirzepatide therapy
They are incredibly popular because the most recent agents result in weight reduction of 20% in a large proportion of the treated populations
The clinical endpoints of interest were: excessive daytime sleepiness, dissociative REM sleep manifestations: cataplexy, sleep paralysis, hypnagogic hallucinations, and early REM sleep (REM sleep naps, SOREMP)
This activation of the PI3K pathway could trigger Protein Kinase B (Akt), a potential enzyme within this pathway that may influence the movement of glucose transporters to the plasma membrane, potentially increasing the uptake of glucose by cells